AGM
AVNS

Alpine Global Management’s Avanos Medical AVNS Stock Holding History

Alpine Global Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,773
Closed -$177K – 243
2025
Q4 		$177K Buy
+15,773
New +$180K 0.04% 214

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Alpine Global Management's AVNS Position: Q1 2026 in Review

Alpine Global Management sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 15,773 shares — an estimated $177K sold.

Alpine Global Management first reported a position in AVNS in Q4 2025 and held it in 1 quarter. The position peaked at $177K in Q4 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Alpine Global Management reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Alpine Global Management sold 15,773 Avanos Medical shares in Q1 2026, an estimated $177K.
  • Alpine Global Management first reported a position in Avanos Medical in Q4 2025 and held it in 1 quarter.
  • Alpine Global Management's Avanos Medical position peaked at $177K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Alpine Global Management's 13F filing for Q1 2026, filed 15 May 2026.